Results
8518
Companies with a Future performance score of at least 3, ordered by Future performance score.
8,518 companies
Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | Industry | ||
---|---|---|---|---|---|---|---|---|---|---|---|
MX1 | AU$0.078 | 0% | -35.0% | AU$45.4m | AU$0.19 | PS3x | E68.7% | n/a | Healthcare | ||
SKS | AU$2.20 | 5.3% | 671.9% | AU$246.6m | AU$2.15 | PE37.2x | E24.8% | 0.5% | Capital Goods | ||
PHM | €91.65 | 8.0% | 152.6% | €1.6b | €86.40 | PE2564.8x | E44.7% | 0.7% | Pharmaceuticals & Biotech | ||
ICOP | €7.82 | -1.3% | n/a | €216.1m | €9.80 | PE42.8x | E49.2% | n/a | Capital Goods | ||
RMDA | ج.م3.59 | -0.3% | 47.7% | ج.م5.4b | ج.م5.02 | PE20.3x | E30.7% | 1.9% | Pharmaceuticals & Biotech | ||
ACE | SEK 2.86 | 0% | -68.9% | SEK 274.9m | SEK 8.25 | PB2.6x | E47.2% | n/a | Pharmaceuticals & Biotech | ||
INIT | SEK 7.25 | 2.1% | -9.4% | SEK 407.0m | SEK 22.50 | PB17x | E31.7% | n/a | Pharmaceuticals & Biotech | ||
RHM | €706.40 | -5.4% | 112.7% | €30.7b | €769.79 | PE44.8x | E30.4% | 0.8% | Capital Goods | ||
FWRY | ج.م8.31 | -3.4% | 51.6% | ج.م28.3b | ج.م12.45 | PE22.9x | E27.4% | n/a | Diversified Financials | ||
AGP | €5.48 | -0.5% | -29.7% | €94.9m | €12.40 | PE14x | E23.3% | n/a | Capital Goods | ||
MBTN | CHF 1.64 | -13.7% | -98.1% | CHF 50.6m | CHF 6.03 | PS0.6x | E109.3% | n/a | Semiconductors | ||
AFISH | NOK 68.00 | 1.5% | 14.3% | NOK 2.2b | NOK 81.00 | PE66.7x | E65.4% | n/a | Food, Beverage & Tobacco | ||
MVW | NOK 9.80 | -3.0% | 12.9% | NOK 320.6m | NOK 11.70 | PS16.7x | E71.7% | n/a | Materials | ||
GUINNESS | ₦77.00 | 0% | 33.9% | ₦168.7b | ₦74.24 | PS0.4x | E119.5% | 0% | Food, Beverage & Tobacco | ||
ELABS | NOK 10.62 | -6.0% | -38.2% | NOK 1.1b | NOK 19.00 | PS12x | E121.1% | n/a | Software | ||
CADLR | NOK 60.00 | 0.7% | 26.0% | NOK 21.0b | NOK 81.41 | PE198.3x | E70.7% | n/a | Capital Goods | ||
TVTX | US$21.86 | 3.8% | 163.4% | US$1.8b | US$28.47 | PS9.4x | E61.9% | n/a | Pharmaceuticals & Biotech | ||
ALKT | US$35.93 | -0.4% | 42.0% | US$3.6b | US$45.10 | PS11.4x | E102.7% | n/a | Software | ||
RCEL | US$9.14 | -3.5% | -48.1% | US$249.5m | US$17.08 | PS4x | E51.9% | n/a | Pharmaceuticals & Biotech | ||
TGTX | US$33.50 | 0.4% | 128.8% | US$4.8b | US$40.33 | PS18.2x | E43.6% | n/a | Pharmaceuticals & Biotech | ||
PRL | CA$37.25 | -8.3% | 122.4% | CA$1.5b | CA$45.92 | PE23.4x | E38.9% | 1.6% | Diversified Financials | ||
AOT | CA$0.14 | -25.6% | -72.6% | CA$137.4m | CA$0.45 | PS9.9x | E89.8% | n/a | Materials | ||
ALNY | US$278.25 | 0.4% | 64.2% | US$35.6b | US$299.74 | PS17.1x | E56.7% | n/a | Pharmaceuticals & Biotech | ||
ZVRA | US$7.88 | -1.7% | 32.4% | US$437.1m | US$20.75 | PS17.2x | E57.4% | n/a | Pharmaceuticals & Biotech |